Hillstream Biopharma Alpha and Beta Analysis
| HILSDelisted Stock | USD 0.39 0.01 2.50% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Hillstream Biopharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Hillstream Biopharma over a specified time horizon. Remember, high Hillstream Biopharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Hillstream Biopharma's market risk premium analysis include:
Beta (0.04) | Alpha (0.57) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Hillstream |
Hillstream Biopharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Hillstream Biopharma market risk premium is the additional return an investor will receive from holding Hillstream Biopharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Hillstream Biopharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Hillstream Biopharma's performance over market.| α | -0.57 | β | -0.04 |
Hillstream Biopharma Fundamentals Vs Peers
Comparing Hillstream Biopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Hillstream Biopharma's direct or indirect competition across all of the common fundamentals between Hillstream Biopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Hillstream Biopharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Hillstream Biopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Hillstream Biopharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Hillstream Biopharma to competition |
| Fundamentals | Hillstream Biopharma | Peer Average |
| Return On Equity | -1.47 | -0.31 |
| Return On Asset | -0.78 | -0.14 |
| Current Valuation | 496.66 K | 16.62 B |
| Shares Outstanding | 17.53 M | 571.82 M |
| Shares Owned By Insiders | 38.90 % | 10.09 % |
| Shares Owned By Institutions | 0.80 % | 39.21 % |
| Number Of Shares Shorted | 52.74 K | 4.71 M |
Hillstream Biopharma Opportunities
Hillstream Biopharma Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Hillstream BioPharma, Inc. Short Interest Update | 04/27/2023 |
2 | Financings for May 3, 2023 - BioWorld Online | 05/03/2023 |
3 | Hillstream BioPharma Announces Strategic Reprioritization of Pipeline to Targeting HER2HER3 Solid Tumors - Benzinga | 07/10/2023 |
About Hillstream Biopharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Hillstream or other delisted stocks. Alpha measures the amount that position in Hillstream Biopharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Hillstream Biopharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Hillstream Biopharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Hillstream Biopharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Hillstream Biopharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Hillstream Biopharma. Please utilize our Beneish M Score to check the likelihood of Hillstream Biopharma's management manipulating its earnings.
| 13th of November 2023 Upcoming Quarterly Report | View | |
| 21st of March 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Hillstream Biopharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Hillstream Stock
If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |